Anemia, renal dysfunction, and their interaction in patients with chronic heart failure.

[1]  N. Dimkovic,et al.  [The cardio-renal anemia syndrome]. , 2007, Medicinski pregled.

[2]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[3]  J. Cleland,et al.  Are hematinic deficiencies the cause of anemia in chronic heart failure? , 2004, American heart journal.

[4]  D. Mancini,et al.  Treatment of anemia in patients with chronic heart failure. , 2004, Journal of Cardiac Failure.

[5]  A. Voors,et al.  Erythropoietin in cardiovascular diseases. , 2004, European heart journal.

[6]  D. Silverberg,et al.  The cardio-renal anaemia syndrome: does it exist? , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  C. O'connor,et al.  Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. , 2003, The American journal of cardiology.

[8]  C. Lang,et al.  Effect of Erythropoietin on Exercise Capacity in Patients With Moderate to Severe Chronic Heart Failure , 2003, Circulation.

[9]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[10]  D. Schwartz,et al.  The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  C. Wanner,et al.  Enzyme replacement therapy for Fabry disease: proving the clinical benefit. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  C. Jurkovitz,et al.  Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.

[13]  G. Fonarow,et al.  Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. , 2002, Journal of the American College of Cardiology.

[14]  A. Struthers,et al.  Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? , 2002, Heart.

[15]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  B. Guida,et al.  Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  E. Antman,et al.  ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .

[18]  W. Rand,et al.  Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. , 2001, Journal of the American College of Cardiology.

[19]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[20]  M J Khoury,et al.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. , 2001, American journal of epidemiology.

[21]  A. Charlesworth,et al.  Renal function, neurohormonal activation, and survival in patients with chronic heart failure. , 2000, Circulation.

[22]  I. Shapira,et al.  The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. , 2000, Journal of the American College of Cardiology.

[23]  M. Domanski,et al.  The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. , 2000, Journal of the American College of Cardiology.

[24]  M. Smithson.  Statistics with confidence , 2000 .

[25]  J. Cleland,et al.  Is the prognosis of heart failure improving? , 2000, European journal of heart failure.

[26]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[27]  A. Rigby.  Statistical methods in epidemiology. III. The odds ratio as an approximation to the relative risk. , 1999, Disability and rehabilitation.

[28]  T. Perneger.  What's wrong with Bonferroni adjustments , 1998, BMJ.

[29]  J. Turney,et al.  Evaluation of RBC ferritin and reticulocyte measurements in monitoring response to intravenous iron therapy. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  R Ottman,et al.  Gene-environment interaction: definitions and study designs. , 1996, Preventive medicine.

[31]  H. Cheong,et al.  Iron Absorption in Patients with Chronic Uremia on Maintenance Hemodialysis and in Healthy Volunteers Measured with a Simple Oral Iron Load Test , 1996 .

[32]  K J Rothman,et al.  The estimation of synergy or antagonism. , 1976, American journal of epidemiology.

[33]  K J Rothman,et al.  Synergy and antagonism in cause-effect relationships. , 1974, American journal of epidemiology.